404 Osteoporosis Flashcards

1
Q

Final common path in osteoclast development and activation

A

Activation of RANK by RANKL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

WHO operational definition of osteoporosis

A

T score of - 2.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cytokine responsible for communication between osteoblast, other marrow cells and osteoclast

A

RANK ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Stimulates bone formation by increasing the activity of osteoclast and decrease RANKL secretion

A

Wnt signaling pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Recommended daily requirement of calcium

A

1000-1200 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Targets of serum 25OHD for optimal skeletal health

A

More than 75 nmol/L or 30 ng/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Important risk factor for osteoporosis and fractures

A

Vitamin D insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanism estrogen deficiency leads to bone loss

A
  1. Activation of remodeling sites

2. Exaggeration of imbalance between bone formation and resoprtion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most common estrogen-deficiency state

A

Cessation of ovarian function at time of menopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does estrogen play a role in bone cells

A

Estrogen can control rate of apoptosis. In estrogen deprivation, life span of osteoblast is decreased and osteoclast in increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Comprises 80% of bone surface area

A

Trabecular bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which has a small surface area: trabecular or cortical bone

A

Cortical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In osteoporosis, where does fracture open occur earliest

A

Where trabecular bone contributes most to bone strength

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Most common early skeletal consequence of estrogen deficiency

A

Vertebral fractures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Most common causes of medication induced osteoporosis

A

Glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Highly accurate x ray technique that is the standard for measuring bone density

17
Q

Preferred site for measurement of bone mineral densitt

18
Q

Alternative area to measure bone mineral density when spine or hip is not measurable

19
Q

At what age is bone mineral density testing recommend to all women

A

Age 65 for females

Age 70 for males

20
Q

When is a patient on glucocorticoids advised BMD testing

A

Prednisone more than 5 mg per day or equivalent for more than 3 months

21
Q

In presence of hypercalcemia, how to differentiate Hyperparathyroidism and hypercalcemia of malignancy

A

Get serum PTH. Hyperparathyroidism has elevated PTH while hypercalcemia of malignancy has low PTH and high PTHrp

22
Q

Suggested by low urine calcium

A

Malnutrition and malabsorption

23
Q

High urine calcium of how much points to hypercalciuria

A

Urine calcium more than 300 mg/24 hours

24
Q

When does hypercalciuria occur

A
  1. Renal calcium leak
  2. Absorptive hypercalciuria which can be idiopathic or increased 1,24 OH2D in granulomatous disease
  3. Hematolofic malignancies associated with excessive bone turnover
25
Treament of renal hypercalciuria
Thiazide diuretics
26
Primary use of biochemical marker
Monitoring response to treatment
27
Most sensitive biochemical marker for bone formation
P1NP
28
When is bone resoprtion measurement done
CTX is done prior to initiating treament and 3-6 months
29
Only currently approved anabolic agent
Teriparatide
30
General pharmacologic therapies for osteoporosis
Antiresorptive | Anabolic
31
Given in combination with estrogen to reduce risk of uterine cancer
Progestin (daily or cyclic at least 12 days per month)
32
Two SERMS approved for use for postmenopausal women for osteoporosis
Tamoxifen | Raloxifene
33
Dosage of alendronate for osteoporosis and for prevention
10 mg/day for osteoporosis | 5 mg/day for prevention
34
GFR when biphosphonates contraindicated
GFR less than 30-35 ml/min
35
Two potential side effects of biphosphonates
Osteonecrosis of the jaw | Atypical femoral fracture
36
Calcitonin is approved for what diseases
Pagets disease Hypercalcemia Osteoporosis in women more than 5 years past menopause
37
Mode of action of calcitonin
Suppress osteoclast activity by direct action on osteoclast calcitonin receptor
38
Humanized antibody that blocks osteocyte production of sclerostin resulting in increased bone formation and define in bone resoprtion
Romosozumab